about
PARAMOUNT trialremdesivirAtrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular EventsAURORA trialVicriviroc in HIV-Treatment Experienced SubjectsPegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerCombination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch RepairProvenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone TherapyEffect of Acid Suppression With Esomeprazole on Vocal Cord GranulomasImaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary SarcoidosisSimple Hygiene Versus Alcohol Based Usual Care for Umbilical CordStudy of INTERCEPT Blood System for Red Blood Cells in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections (RedeS)SHORT-HER: MULTICENTRIC RANDOMISED PHASE III TRIAL OF ADJUVANT CHEMOTHERAPY PLUS 3 VS 12 MONTHS OF TRASTUZUMAB IN BREAST CANCER PATIENTS WITH HER2 POSITIVE DISEASEMethods in Education for Breast Cancer GeneticsThe Effect of Administration of Low Dose Adrenaline During Surgery on Bleeding During Hip SurgeryStudy of Efficacy and Safety of Brodalumab Compared With Placebo and Ustekinumab in Moderate to Severe Plaque Psoriasis SubjectsStudy of Efficacy, Safety, and Withdrawal and Retreatment With Brodalumab (AMG 827) in Moderate to Severe Plaque Psoriasis SubjectsThe Effects of Corneal Collagen Cross-linkingParaspinal Stimulation in Treating MPSThe Effect of Topical Lidocaine on Pain Scores During Manual Vacuum Aspiration for Nonviable PregnanciesDIetary Supplements, Executive funcTions and Vitamin D (DIET-D)The Efficacy, Safety, and Tolerability of Laquinimod in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel TherapyEfficacy of Midodrine for the Prevention of Orthostatic Hypotension During Early Mobilization After Fast-track Hip ArthroplastyAdjusted Value of Thromboprophylaxis in Hospitalized Obese Patients: A Comparative Study of Two Regimens of EnoxaparinNonivamide/Nicoboxil Ointment in Acute Low Back PainStudy to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 PatientsP. Knowlesi Trial of Artesunate-mefloquine Versus ChloroquineStudy of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast CancerThe Effect of Chinese Herbal Formula (KSY) on HCV Carrier With Abnormal Liver FunctionThe Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver TransplantationProphylactic Use of Milrinone After Congenital Heart Surgery in InfantsEPASS Versus Uncovered Duodenal Stent for Unresectable Malignant Gastric Outlet Obstruction.Study of COR388 HCl in Subjects With Alzheimer's DiseaseA Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (LUCERNE)A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate CancerA Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a "2+1"Sequential Schedule With bOPV in InfantsA Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a '1+2' Sequential Schedule With bOPV in InfantsStudy of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia
P6099
list of Phase III Cancer Clinical Trials 2014list of Phase III Cancer Clinical Trials 2015Chlorproguanil-dapsone-artesunate versus artemether-lumefantrine: a randomized, double-blind phase III trial in African children and adolescents with uncomplicated Plasmodium falciparum malariaLong-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west UgandaA phase III randomized three-arm trial of physical therapist delivered pain coping skills training for patients with total knee arthroplasty: the KASTPain protocolRandomized Phase III Trial of Retinoic Acid and Arsenic Trioxide Versus Retinoic Acid and Chemotherapy in Patients With Acute Promyelocytic Leukemia: Health-Related Quality-of-Life OutcomesEmbracing failure: What the Phase III progesterone studies can teach about TBI clinical trialsSodium oxybate therapy provides multidimensional improvement in fibromyalgia: results of an international phase 3 trialThe trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trialProtocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) ..Anatomical effects of dexamethasone intravitreal implant in diabetic macular oedema: a pooled analysis of 3-year phase III trialsPhase III trial of postoperative cisplatin, interferon alpha-2b, and 5-FU combined with external radiation treatment versus 5-FU alone for patients with resected pancreatic adenocarcinoma -- CapRI: study protocol [ISRCTN62866759]Expression profiling of blood samples from an SU5416 Phase III metastatic colorectal cancer clinical trial: a novel strategy for biomarker identificationlist of Phase III Cancer Clinical Trials 2016Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139].Brodalumab for the Treatment of Psoriasis: A Review of Phase III TrialsStudy Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials)Designing phase 3 sepsis trials: application of learned experiences from critical care trials in acute heart failureIxekizumab for the Treatment of Psoriasis: A Review of Phase III TrialsBiomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological ReviewReporting quality of abstracts in phase III clinical trials of systemic therapy in metastatic solid malignanciesNovel agents for multiple myeloma to overcome resistance in phase III clinical trialsMeta-analysis of phase III trials of docetaxel alone or in combination with chemotherapy in metastatic breast cancerEditor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trialsRole of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic reviewOverview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanomaEfficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.Randomized phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas in the Radiation Therapy Oncology Group 0129 trial: long-term report of efficacy and toxicity.Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: a phase III metastatic castration resistant prostate cancer trial.Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children. Results of a phase 3 trial.Methodology of the Field Administration of Stroke Therapy - Magnesium (FAST-MAG) phase 3 trial: Part 2 - prehospital study methodsThe new oral anti-coagulants and the phase 3 clinical trials - a systematic review of the literatureOpen-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.FOXP3 expression in cancer cells and anthracyclines efficacy in patients with primary breast cancer treated with adjuvant chemotherapy in the phase III UNICANCER-PACS 01 trial.Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial.Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial.
P921
Q17148583-057EBFB3-69E9-4D46-83E8-1CF77C22FD07Q28209496-f87f8990-40a0-562f-9ece-3be867f71d92Q288786-17BEC035-C664-4DB6-BC4F-78F991C3E819Q4654994-6E41E1B5-D43D-4561-B9AC-3BF182A02A27Q47683789-6C6BEB79-D950-4FE7-B63E-615193C3C916Q58845627-F1526B33-C6C6-4D6B-A8C5-9E46D11A8D2EQ58845885-6B2F3C61-A95F-47A6-8142-C4196FBFB994Q58848980-3d4cb277-4237-c356-374a-30309b2f5fedQ59772547-B9F97973-2527-4EA2-8C8F-4F8A3EF8D91EQ59772548-FD83BD2D-DFB0-43BA-B151-C5A6DAD5EC37Q59772550-93FD6D78-EAD7-45CA-8914-0B648F00D823Q60563354-4A63EA8F-B96A-4F6F-995F-00DC3C33CE60Q60757295-9164ab62-48c8-8ce4-9be9-197316a7a890Q61694852-C2D35CD0-2511-42CC-821D-E1EE32E186C7Q61707384-ED7EEED9-535C-4086-88D7-BB99431BDBA2Q61707386-A26AB5FD-6781-4E6D-BB0E-62005E3C8558Q61707389-3C74BFEB-019F-42B7-85B1-1A2CF0A0BCB9Q61707395-291C0599-12A7-4F36-8D43-82805294422EQ61707413-56D6A665-7430-4672-BF78-F8130E0C70CBQ61707415-F4F2C114-858C-4DB0-B8B1-2F2A261524ACQ61707444-7FE2C584-D547-4902-919A-2023F0089675Q61707445-86DF62A7-B371-48C5-9A0A-FA800FB60F1EQ61707448-207CD729-8229-4FDF-9918-FBDA1EE44370Q61707449-7AD87DE4-5CC7-44BF-8A58-8D43B65BBF13Q61707471-F0C1E680-5B88-4DB8-87B8-53D3188882DAQ61713091-6A9875BA-400A-4BB6-A703-587104BE5215Q61713093-7688999C-23C5-44FF-81B1-793BA396506BQ61713095-1C50BDCD-92F7-4A61-B283-85FE1DFF316EQ61713103-5EBD430E-A937-4E8D-BB20-51786413D74AQ61713108-CA01A624-E8E2-446E-B80C-DD9985CFE28EQ61713181-02FDB6EA-CA3C-445C-A5F7-F09BFE284862Q61727917-CD45E221-CD1F-4F28-8E14-DD27129246E7Q61727921-E6B2AA7E-6EA5-4169-A634-15AB921D3208Q61727943-A3B0F6D5-92EE-40FD-91EF-27903641643EQ61727955-D6BCD1B8-8C04-49F5-87B7-439DB0D18506Q61727957-5C76DDDD-2C8C-49CA-B5C2-90F8EC2068DBQ61727986-DC965E15-C4A1-4E12-B4B2-AF529065CA6AQ61727992-2C9CF0B8-4686-4A7F-8849-A463016163E5Q61727993-2AC8ACB4-2981-4897-A1F2-7297CA36B27DQ61728009-B0B1DF27-C616-4D11-A11F-BA48F5C611D4
P6099
Q18347921-8A18C6F4-D480-4EBD-A406-C188262C94E8Q19597755-729CB432-498A-4EED-AB34-7A61F4A951B9Q21143739-00388F7C-80EE-4632-9FDF-654108E60B83Q21203732-686E1860-237D-4D10-AD5F-5F8ED0E5465FQ21257171-DE728BAB-1CF3-45E8-B1D3-725454D0A5D7Q23671265-E5FE1733-0432-48A5-98CC-4DA7DC1323D0Q24273391-6474099E-F4C9-4963-9B70-65D96AFC23D9Q24607936-0EF032BD-A3DF-41FD-A772-93EF8A9109F2Q24629295-F390D7F4-A5BA-43EE-92E5-B98106AE60C5Q24658529-0ABAD625-95C0-4E3E-8815-BDACC8BDC149Q24658545-F92A7C63-702A-4DBC-A169-6D99EAC34B00Q24792780-25E41314-9EEE-4384-8435-58DF1952E7ECQ24806443-3679BEF8-0F68-4FF8-B4B0-12E631E679FDQ25110060-618DD539-86AB-4FE2-AE99-DB1CAC4CC885Q25256974-5E29E580-22B3-4626-B827-CB9D17E8E30AQ26746100-1EBD4877-618C-4099-9DB1-72E1CA13B008Q26747940-AFB01AC4-2966-4EF5-98CB-2327B7EC23CDQ26749027-129C126A-7445-4D4F-82AA-9C3F0BC0DA39Q26766567-57512C76-03D5-4196-9658-F311CBA06FE3Q26766584-4CEAADE8-CE20-42F9-8851-CBCEECE1E2D3Q26801019-43EA2B81-9F71-4044-B244-3C06CB38FED9Q26822754-B42458F7-E308-44C5-9867-BA5B5E8DBFC8Q26860469-C4693283-7CA7-41D1-90C8-03B96ECC270BQ27023414-3C257AD7-0ABC-4DD6-B4D6-181259DF7FE7Q27025724-8EC9AB44-29E9-47B3-865C-E2D00A941F7EQ27027762-1C977FBD-AD83-4EAF-9E85-528E4475BB2DQ27313312-C4C3A9E8-3E52-49C3-BCAD-864C047F5B06Q27313572-DD01E04F-35F8-4771-B43B-8928CE09EAD0Q27334654-DF5D9B45-BAA8-4D9C-9D21-4434AC99B264Q27342796-AAFFA206-5F15-4529-AB48-92D679BB3025Q27349435-CBB15111-9495-44DF-B9C5-92FCAD3288BEQ27497485-ABCC17A3-3D85-4691-A69B-F3BFFCA8753FQ27851407-B529FF0A-7B5E-44D4-8DDB-A890783ED558Q27851578-AB287793-514B-4721-9C8A-43254998F31EQ27851705-8B687A4A-1490-4495-B389-30B4BE611AD0Q27851712-768C1D77-1DA1-41D8-BA45-340F5021D961Q27851740-35DC8475-A058-4596-BC8D-65A500E3FD98Q27852333-AD3A5F7A-E68D-4F07-B68D-3227034CF463Q27852787-94A231BA-07C4-47F7-960A-F8CB47620AF4Q27852908-23F55965-0A26-44A6-9919-55D2C4AB8FD3
P921
description
advanced phase of a clinical t ...... reatment to an established one
@en
fase avanzada de un estudio cl ...... atamiento nuevo con uno previo
@es
pokročilá fáze klinického hodnocení nového léku
@cs
被験薬が従来の薬より効果があるかを比較することを目的とする、治験における段階
@ja
name
Phase-III-Studie
@de
essai clinique phase 3
@fr
fase 3 d'assaig clínic
@ca
fase 3 de ensayo clínico
@es
faza a treia a studiul clinic
@ro
klinische proeffase III
@nl
phase III clinical trial
@en
studie III. fáze
@cs
фаза III клиничког тестирања
@sr
المرحلة الثالثة للتجربة السريرية
@ar
type
label
Phase-III-Studie
@de
essai clinique phase 3
@fr
fase 3 d'assaig clínic
@ca
fase 3 de ensayo clínico
@es
faza a treia a studiul clinic
@ro
klinische proeffase III
@nl
phase III clinical trial
@en
studie III. fáze
@cs
фаза III клиничког тестирања
@sr
المرحلة الثالثة للتجربة السريرية
@ar
altLabel
3. fáze klinického hodnocení
@cs
Klinik Phase 3
@de
Klinik Phase III
@de
Phase-3-Studie
@de
fase III de ensayo clínico
@es
faza 3
@ro
faza a III-a
@ro
faza a treia
@ro
fáze III klinického hodnocení
@cs
phase 3 clinical trial
@en
prefLabel
Phase-III-Studie
@de
essai clinique phase 3
@fr
fase 3 d'assaig clínic
@ca
fase 3 de ensayo clínico
@es
faza a treia a studiul clinic
@ro
klinische proeffase III
@nl
phase III clinical trial
@en
studie III. fáze
@cs
фаза III клиничког тестирања
@sr
المرحلة الثالثة للتجربة السريرية
@ar
P672
P279
P3712
P672
E05.318.372.250.250.220
N05.715.360.330.250.250.220
N06.850.520.450.250.250.220
V03.175.250.300